Recommended Topic Related To:

Viracept

"The combinations of anti-HIV drugs recommended for pregnant women do not appear in general to increase their children's risk for language delay, according to a study from a National Institutes of Health research network.

Children ex"...

Viracept

Indications
Dosage
How Supplied

INDICATIONS

VIRACEPT in combination with other antiretroviral agents is indicated for the treatment of HIV-1 infection.

DOSAGE AND ADMINISTRATION

Adults and Adolescents (13 years and older)

The recommended dose is 1250 mg (five 250 mg tablets or two 625 mg tablets) twice daily or 750 mg (three 250 mg tablets) three times daily. VIRACEPT should be taken with a meal. Patients unable to swallow the 250 or 625 mg tablets may dissolve the tablets in a small amount of water.

Pediatric Patients (2 to less than 13 years)

In children 2 years of age and older, the recommended oral dose of VIRACEPT Oral Powder or 250 mg tablets is 45 to 55 mg/kg twice daily or 25 to 35 mg/kg three times daily. All doses should be taken with a meal. Doses higher than the adult maximum dose of 2500 mg per day have not been studied in children.

For children unable to swallow tablets, VIRACEPT 250 mg tablet(s) may be dissolved in a small amount of water or, VIRACEPT Oral Powder may be administered.

The healthcare provider should assess appropriate formulation and dosage for each patient. Tables 1 and 2 provide dosing guidelines for VIRACEPT tablets and powder based on age and body weight.

Table 1: Dosing Table for Children 2 to less than 13 years of age (tablets)

Body weight
Kg
Twice daily (BID)
45 — 55 mg/kg
≥ 2 years
Three times daily (TID)
25 - 35 mg/kg
≥ 2 years
Number of tablets
(250 mg)
Number of tablets
(250 mg)
10-12 2 1
13-18 3 2
19-20 4 2
≥ 21 4-5* 3
*For BID dosing, the maximum dose per day is 5 tablets BID
For TID dosing, the maximum dose per day is 3 tablets TID

Table 2: Dosing Table for Children 2 to less than 13 years of age (powder)

Body weight Twice daily (BID)
45 - 55 mg/kg
Three times daily (TID)
25 - 35 mg/kg
Kg Scoops of powder
(50 mg/1 g)
Teaspoons* of powder Scoops of powder
(50 mg/1 g)
Teaspoons* of powder
9.0 to <10.5 10 6
10.5 to <12 11 7
12 to <14 13 8 2
14 to <16 15 9
16 to <18 Not recommended Not recommended 10
18 to <23 Not recommended Not recommended 12 3
≥ 23 Not recommended Not recommended 15
*If a teaspoon is used to measure VIRACEPT oral powder, 1 level teaspoon contains 200 mg ot VIRACEPT (4 level scoops equals 1 level teaspoon)
Use VIRACEPT 250 mg tablet

Method of Administration

For Patients Unable to Swallow Viracept Tablets
  • Place VIRACEPT tablet(s) in small amount of water.
  • Once dissolved, mix the cloudy liquid well, and consume it immediately.
  • The glass should be rinsed with water and the rinse swallowed to ensure the entire dose is consumed.
Viracept Oral Powder
  • Mix VIRACEPT Oral Powder with a small amount of water, milk, formula, soy formula, soy milk, or dietary supplements
  • Once mixed, the entire contents must be consumed in order to obtain the full dose.
  • If the mixture is not consumed immediately, it must be stored under refrigeration, but storage must not exceed 6 hours.
  • Acidic food or juice (e.g., orange juice, apple juice, or apple sauce) are not recommended for mixing VIRACEPT Oral Powder because the combination may result in a bitter taste.
  • VIRACEPT Oral Powder should not be reconstituted with water in its original container.

Hepatic Impairment

VIRACEPT can be used in patients with mild hepatic impairment without any dose adjustment. VIRACEPT should not be used in patients with either moderate or severe hepatic impairment [see WARNINGS AND PRECAUTIONS, Use in Specific Populations, and CLINICAL PHARMACOLOGY].

HOW SUPPLIED

Dosage Forms and Strengths

VIRACEPT 250 mg Tablet: Light-blue, capsule-shaped tablets with a clear film coating engraved with "VIRACEPT" on one side and "250 mg" on the other.

VIRACEPT 625 mg Tablet: White oval tablet with a clear film coating engraved with "V" on one side and "625" on the other. VIRACEPT Oral Powder: Off-white powder containing 50 mg (as nelfinavir-free base) in each level scoopful (1 gram).

VIRACEPT (nelfinavir mesylate) 250 mg: Light-blue, capsule-shaped tablets with a clear film coating engraved with "VIRACEPT" on one side and "250 mg" on the other.

Bottles of 300 (250 mg) tablets -NDC 63010-010-30

VIRACEPT (nelfinavir mesylate) 625 mg: White oval tablet with a clear film coating engraved with "V" on one side and "625" on the other.

Bottles of 120 (625 mg) tablets -NDC 63010-027-70

VIRACEPT (nelfinavir mesylate) Oral Powder is available as a 50 mg/g off-white powder containing 50 mg (as nelfinavir free base) in each level scoopful (1 gram).

Multiple use bottles of 144 grams of powder with scoop.......NDC 63010-011-90

VIRACEPT tablets and oral powder should be stored at 15° to 30°C (59° to 86°F).

Keep container tightly closed. Dispense in original container.

Distributed by: ViiV Healthcare Company, Research Triangle Park, NC 27709. Revised: April 2012

Last reviewed on RxList: 4/20/2012
This monograph has been modified to include the generic and brand name in many instances.

Indications
Dosage
How Supplied
A A A

Viracept - User Reviews

Viracept User Reviews

Now you can gain knowledge and insight about a drug treatment with Patient Discussions.

Here is a collection of user reviews for the medication Viracept sorted by most helpful. Patient Discussions FAQs

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


WebMD Daily

Get breaking medical news.